ME agenda

Myalgic Encephalomyelitis | political issues | information | commentary | for the UK ME patient community

Archive for the ‘MSBP (FII)’ Category

Medically Unexplained Psychologising of ME (MUPs) by Peter Kemp

Posted by meagenda on November 10, 2009

An essay by Peter Kemp orginally published on Co-Cure

WordPress Shortlink: http://wp.me/p5foE-2lq

 

Medically Unexplained Psychologising of ME (MUPs)

Permission to repost

10 October 2009

In this essay I will explore some psychic phenomena that might be relevant to psychologising of illness.

Generalisations cannot practically be made, MUPs is not just heterogeneous from a psychic viewpoint – it is likely to be individual. So I can only explore my impressions and I hope you will read my theories as falling somewhere between the Origin of Speciousness and A Tale of Two Settees.

Use of some terminology has been unavoidable but I include a few definitions and illustrations as ‘Asides’ that I hope will help make the essay accessible to PWME.

Peter Kemp

Acronyms:

PWME = Person (or People) With ME

MUPs = Medically Unexplained Psychologising of ME

 

Medically Unexplained Psychologising of ME (MUPs)

Aside 1

AN ILLUSTRATION OF ‘PROJECTION’

Jack thinks that it would be very bad to be envious; this might be something his parents taught him. He notices envy in other people and condemns them for being envious. The envy that he so often notices might be real or not, it does not matter because it is HIS envy he is seeing. He is Projecting his envy onto other people to try and hide and control it within himself.

WITHDRAWAL OF PROJECTION

Projection is an unconscious process, people are not aware when they are doing it, but if they can become aware of the true source of a problem there may be an opportunity for growth.

One day Jack says to Jill, ‘I think you are envious of Mary’s little lamb’; and Jill says, ‘actually, I love Mary so much I gave her that lamb. I think you are envious because I get on so well with Mary.’ Jack’s theories fall apart and his projection is laid bare. If he is honest and humble enough he can then discover his own envy and stop projecting it. It may help if Jill points out ‘what’s wrong with being envious anyhow? It is part of how I know what I like and what I want’.

Through this uncomfortable experience Jack stops projecting envy and finds that natural feelings of envy can help him to make decisions about what he wants in life.

———————————————

Projected Fear

PWME represent ‘ideal’ subjects for the projection of all sorts of fears, Fear of losing control, Fear of weakness, Fear of illness, Fear of physical inadequacy, and perhaps worst of all, Fear of fear. For some MUPs I suspect that subtler projections and issues arise, such as Fear of being wrong and Fear of being misunderstood. All these fears have their roots in the psyche and are most troublesome when their origins are unconscious and when strongly denied. This may result in odd behaviour that may nevertheless be easily justified, but the justifications do not reveal the true motives behind the behaviour, instead they contribute to their concealment.

To confront fear it must be acknowledged but if it originates from an intense inner conflict it might be that the ego is not ready to withstand it. In these circumstances an internal struggle is maintained to repress some aspects of a complex in order to protect the ego. Enacting these conflicts in the world is a common way of reinforcing defences and avoids addressing the conflict directly. Unfortunately, this never resolves the issue at its source and means that substitute conflicts must constantly be found. As such projecting Fear may be predisposing and initiating; and because projection is an avoidance strategy, it is likely to be a maintaining factor in MUPs.

Withdrawal of Projection

For some people in whom contact with PWME arouses issues with fear, the psyche may seize this as an opportunity for growth. If someone projects fear onto another they may sometimes be able to compare their projection with the actual person. If discrepancies are found then the projection might start to weaken, then the projector has an opportunity to challenge and eventually withdraw the projection.

For example; a person fearful of losing control might project this onto a PWME; if they then realize that the PWME is actually coping well (with what for many people is a terrifying aspect of disability), the projector may think something like; ‘I thought he was weak, but I could not cope so well with such a loss of control’. This represents a stage of withdrawal of a projection as the projector has discovered that the source of the fear is within himself. Such situations might be considered MUPs based on transient / opportunistic factors; and is I suspect, a very common occurrence. Some MUPs might be able to relate to this if they find they vacillate between impatience and respect towards a PWME. This could be a sign that projections are weakening and the source of fear might be discoverable. Read the rest of this entry »

Posted in Benefits, CBT/GET, Care, Child protection, DSM revision process, Elephant Series DSM-V, ICD revision process, ICD-11, ME in children, MSBP (FII), MUPSS Project, MUS | Comments Off

25% ME Group announces Byon Hyde MD as new Patron and Medical Advisor

Posted by meagenda on November 6, 2009

The 25% ME Group has announced, today, that US Dr Byon Hyde, MD, is taking up the role of new Patron and Medical Advisor to this organisation for the severely affected.  The Countess of Mar had been a long time Patron to the 25% ME Group but was asked to stand down early this year following the NICE Guideline debacle.

WordPress Shortlink: http://wp.me/p5foE-2kj

25% ME Group  http://www.25megroup.org

PERMISSION TO REPOST

The 25% ME Group is pleased to report the appointment of their new Patron and Medical Advisor.

We are absolutely delighted to announce that Dr Byron Hyde will be taking up the role with immediate effect.

Dr Byron Hyde is leading physician and researcher specialising in Myalgic Encephalomyelitis (ME) and has worked exclusively with ME patients since 1985.

He is the founder and chairman of the Nightingale Research Foundation which is dedicated to explore, understand and treat patients disabled with ME and is at the forefront of the struggle to draw a clear distinction between ME and the current definitions of Chronic Fatigue Syndrome. In 1992 he published the medical reference book still used by researchers internationally “The Clinical and Scientific Basis of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome”.

Dr Byron Hyde is an outspoken critic of the role psychiatry has played in ME. His entreaty that “Psychiatrists should not ever be placed in charge of diagnosis and treatment of M.E. patients” is one we fully support.

Dr Byron Hyde has been instrumental in bringing about recognition of ME as a serious illness and we feel he fully represents the interests and aims of the 25% ME Group. We are proud to have him as our Patron.

We also take great pleasure in announcing our new additional Medical Advisor, Dr Nigel Speight, who, as you will read below, recently departed from AYME. We are extremely pleased to have Dr Speight on board as he is a highly respected medical professional within the ME field and a great advocate for the biomedical view of ME.

Below we have posted resignation letter from Dr Nigel Speight to AYME (Young Childrens’ ME Charity) for your information.

Dear all

I just thought I should inform you officially that after a long and happy association with AYME I have decided to resign as their Patron. Without going into too much detail I would say that over the last couple of years I have become aware that they have changed their position on several areas and that our views have accordingly diverged.

In particular AYME seem to have become more willing to collaborate with the medical and psychiatric establishment in order to appear respectable. This appears to have been the cause of AYME’s relative enthusiasm for the NICE Guidelines, which most of us feel involve an overemphasis on CBT and GET. This compromise seems to have helped the psychiatrists to get a new lease of life.

The result of all this is that AYME appear to have alienated themselves from most of the other ME charities (with the exception of AfME who appear to be taking a similar position). In this controversy I feel more in sympathy with the rest of you.

I have gained the impression that AYME no longer appreciate my opinions and prefer my status as their figurehead to be a largely silent one.

It is a combination of all these factors that has caused me to resign and I am sure you will all understand.

With Best Wishes

Nigel Speight

We are especially delighted to announce the new Patron and Medical Advisor for our Group because as many of you will know, both stand for the true recognition and research of ME (as opposed to including it along with other Chronic Fatigue conditions). They also are firmly opposed to any psychological intervention within the area of ME.

We hope you will be delighted along with us regarding this news and please feel free to report or republish this information within your own publications etc.

With best wishes

Simon Lawrence

Chairperson

25% ME GROUP

21 Church Street
Troon
Ayrshire
KA10 6SQ

enquiry@25megroup.org

www.25megroup.org

Posted in 25% ME Group, AYME, CFS Research, Child protection, Countess of Mar, ME Research, MSBP (FII) | Comments Off

XMRV Retrovirus Round up 22: WPI Press Release, ESME, 74 CFSAC meeting videos

Posted by meagenda on November 5, 2009

XMRV Retrovirus   Whittemore Peterson   Institute Science   Mikovits   Peterson   Chronic Fatigue Syndrome

XMRV Retrovirus: Round up 22: WPI Press Release, ESME, 74 CFSAC meeting videos

WordPress Shortlink: http://wp.me/p5foE-2jN

Press Releases

PDF here: WPI Release Diagnostic Test

http://www.wpinstitute.org/WPI%20Release%20Diagnostic%20Test.pdf

FOR IMMEDIATE RELEASE

Frankie Vigil
R&R Partners
775-336-4555
frankie.vigil@rrpartners.com

Viral Immune Pathology Diagnostics Introduces New Test for XMRV Patients and Clinicians
-Net proceeds from test dedicated to further WPI research-

RENO, Nev. – The Whittemore Peterson Institute (WPI) has recently published a research study revealing the prevalence of XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, ME/CFS or what has most recently been called, X associated neuro-immune disease, (XAND). In response to an overwhelming request for a diagnostic test for XMRV, WPI has temporarily agreed to allow Viral Immune Pathology Diagnostics (VIP Dx) to begin offering the identical tests that have been extensively validated using the same technology developed by Drs. Lombardi and Mikovits and their colleagues as reported in Science.

VIP Dx is a small state certified laboratory in Reno, Nevada that was formed in response to the September 11, 2001 crisis which resulted in the cessation of blood sample shipments between the United States and Europe. Faced with the loss of important lab tests impacting patients with neuro-immune diseases, the Whittemore family made the decision to support the lab in Reno.

“Our family made it possible for the lab to not only continue delivering diagnostic tests to doctors, but also help the WPI bring cutting edge biomarkers of disease to this field of medicine, such as the tests for XMRV,” said Annette  Whittemore, Founder and President of WPI. “Tests conducted for XMRV, and other tests that support the diagnostic process in this field, will support the continuation of vital work at WPI through our donation of all of our net proceeds.”

XMRV test acceptance commenced at VIP Dx this month.

For more information about the XMRV test kit, visit www.vipdx.com

Whittemore Peterson Institute  http://www.wpinstitute.org/

The Whittemore Peterson Institute for Neuro-Immune Disease exists to bring discovery, knowledge, and effective treatments to patients with illnesses caused by acquired dysregulation of the immune system and the nervous system, often resulting in lifelong disease and disability. The WPI is the first institute in the world dedicated to neuro immune diseases, integrating patient treatment, basic and clinical research and medical education.

—————-

CFSAC Two Day meeting: NIH videocasts now available plus 74 Video segments

http://cfsknowledgecenter.ning.com/video

74 videos covering the CFSAC Two Day meeting (29 – 30 October) on Dan Moricoli’s Ning ME-CFS Community.

—————-

NIH will be counting viewing figures to assess interest in making videocasts for these meetings available worldwide – so please view the videocasts on the NIH site:

Videocasts of CFSAC meeting 29-30 October 2008

Around 12 hours of video of the two day CFSAC meeting is now available at:

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 1
Thursday, October 29, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 06:43:49

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2
Friday, October 30, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 05:15:09

Presentation

Dr David Bell’s PowerPoint slides: http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt

———-

Media

The Street   |  3 November 2009

http://www.thestreet.com/_yahoo/story/10620979/1/hemispherx-cops-to-ampligen-fda-delay.html

Ref: Hemispherx press release:

http://finance.yahoo.com/news/Hemispherx-Biopharma-Updates-pz-1535703186.html 

See also:

http://philadelphia.bizjournals.com/philadelphia/stories/2009/11/02/daily2.html

Hemispherx cops to Ampligen FDA delay

PHILADELPHIA, Pa. (TheStreet) – Hemispherx Biopharma(HEB Quote) issued an “update” to the regulatory status of its chronic fatigue syndrome drug Ampligen in which the company essentially admits that its prior public statements were false and misleading.

Monday’s statement was likely crafted by Hemispherx’s lawyers as a way to help CEO Bill Carter wiggle out of public statements he made in May and June claiming the Ampligen application to the U.S. Food and Drug Administration to be complete. Carter insisted regulators weren’t asking for any additional information on Ampligen.

Read full article here

—————-

Patient organisation statements

ESME www.esme-eu.com

Dear Whittemore Peterson Institute,

The Scientific Panel, the Board of Directors and the staff of ESME wish to congratulate the Whittemore Peterson Institute on the groundbreaking work they are performing in the area of neuro-immune diseases and especially their work with the XMRV virus. We applaud the thoroughness of your research and the openness with which you are sharing this research information with the world. We believe that by sharing scientific knowledge with this openness, you are starting a new era of scientific cooperation.

ESME would like to help the Whittemore Peterson Institute with information flow in Europe. We have the capacity to professionally translate information to Danish, Dutch, German, Norwegian, French and Spanish and we have a professional website where information can be posted in any of these languages: www.esme-eu.com  

ESME has also established a database of approximately 3000 e-mail addresses of European scientists, doctors, medical associations, national and regional ME associations, politicians, journalists and other people interested in ME/CFS. This database allows us to easily distribute information to professionals in many fields. We will gladly use our resources to assist the Whittemore Peterson Institute with the distribution of information in Europe.

In 2009, ESME held two conferences in Norway to educate healthcare personal (and patients) about the diagnostics, treatment, causes and consequences of ME/CFS. ESME will continue organizing these conferences in the coming years throughout Europe. We would like to invite a representative of the WPI to be a guest speaker at future European conferences to help us inform and train European MD’s and therapists better.

With Kind Regards,

ESME

—————-

Commentary

Cort Johnson’s Phoenix Rising website: http://aboutmecfs.org/Rsrcs/XMRVResources.aspx

Cort Johnson’s Blog and comments: http://aboutmecfs.org/blog/

Cort Johnson’s Forums: http://forums.aboutmecfs.org/

—————-

About.com  Fibromyalgia  and CFS Blog  | 5 November 2009

XMRV & Updated Mechanism Theory of Chronic Fatigue Syndrome

The XMRV Discovery Series

Dr. Daniel Peterson, one of the researchers involved in the possibly groundbreaking XMRV findings, testified before the NIH’s Chronic Fatigue Syndrome Advisory Committee Oct. 29. Among the many things he presented was an updated theory of how chronic fatigue syndrome (CFS or ME/CFS) develops. (Thanks to Dr. David S. Bell and his newsletter, Lyndonville News for putting this into language that was easier to understand!)

Read full article here

—————-

For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, go here: http://wp.me/p5foE-272

For Science paper go here: http://wp.me/p5foE-2is

Click here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus: Round up 21: CFSAC videocasts, Testing, Media, CDC Chatter Blog

Posted by meagenda on November 3, 2009

XMRV Retrovirus   Whittemore Peterson   Institute Science   Mikovits   Peterson   Chronic Fatigue Syndrome

XMRV Retrovirus: Round up 21: CFSAC videocasts, Testing, Media and CDC Chatter Blog

WordPress Shortlink: http://wp.me/p5foE-2iU

Videocasts of CFSAC meeting 29-30 October 2008

Around 12 hours of video of the two day CFSAC meeting is now available at:

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 1
Thursday, October 29, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 06:43:49

———-

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2
Friday, October 30, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 05:15:09

Presentation

Dr David Bell’s PowerPoint slides: http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt

Public Testimony
Thursday, October 29, 2009

List of those given testimony plus some PDFs

Friday, October 30, 2009

List of those given testimony plus some PDFs

Written Testimony Received Prior to the Meeting Date

26 PDFs

—————

YouTubes of CFSAC meeting

Clips of Dr Dan Peterson’s presentation and Annette Whittemore: http://www.youtube.com/user/Khalyal

Also on this channel plus some patient testimonies: http://www.youtube.com/user/luminescentfeeling

Dr Dan Peterson presentation in 11 parts here: http://www.youtube.com/user/luminescentfeeling#p/u/11/80yKflt0tcA

—————

Media

Reno Gazette Journal  | 3 November 2009

http://www.rgj.com/article/20091103/NEWS/911030349/1321/news

Hundreds request test for retrovirus
BY LENITA POWERS • lpowers@rgj.com

Overwhelmed by requests from people seeking to have their blood tested for a new retrovirus discovered by researchers at the Whittemore-Peterson Institute for Neuro-Immune Disease in Reno, the institute has arranged for a local laboratory to do the testing.

The flood of requests for blood tests began after the Whittemore-Peterson Institute published a research study in the Oct. 8 online journal Science that showed the prevalence of the retrovirus XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Viral Immune Pathology Diagnostics (VIP Dx), a small state-certified laboratory in Reno, temporarily will provide testing for the retrovirus XMRV for physicians who request it for their patients at a cost ranging from $400 to $650.

Institute officials said the hope to enter an agreement with a larger laboratory that could handle the demand nationwide, Annette Whittemore, the institute’s founder and president, said Monday…

Read full article here

———————

ProHealth  |  3 November 2009

http://www.prohealth.com/library/showarticle.cfm?libid=14982

Dr. Bell’s November Newsletter – Lyndonville Research Group ‘Back in Business’ with Presentations Planned

Issued in the wee hours of November 3, 2009, Dr. David Bell’s latest free Lyndonville News e-newsletter (http://www.davidsbell.com/index.htm#Latest  announces that the revived Lyndonville ME/CFS Research Group has already initiated four projects, the first being a presentation Dr. Bell will give Sunday, Dec 6 in Batavia, New York “Between Rochester and Buffalo,” fee $10 to cover costs…

Read full article here

——————

University of Florida  College of Medicine  |  3 November 2009

http://news.medinfo.ufl.edu/articles/miscellaneous/event/chronic-fatigue-syndrome-cancer-linked-to-new-virus/

By Czerne Reid

A newly identified virus has been found to be linked to chronic fatigue syndrome and might also provide clues about how to prevent prostate cancer, according to a report this month in the journal Science. Called XMRV, the virus is transmitted in blood and body fluids and might be a significant public health threat.

Judy Mikovits, Ph.D., senior author of the paper, described the research during grand rounds at the University of Florida College of Medicine Thursday, Oct. 20. She was a guest of the division of hematology/oncology…

Read full article here

——————

Reuters Hemispherx Press Release

http://www.reuters.com/article/pressRelease/idUS124102+02-Nov-2009+GNW20091102

Hemispherx Biopharma Updates Chronic Fatigue Syndrome (CFS) Treatment and Commercial…

Mon Nov 2, 2009 8:46am EST

Hemispherx Biopharma Updates Chronic Fatigue Syndrome (CFS) Treatment and Commercial Application Programs

PHILADELPHIA, Nov. 2, 2009 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the “Company”), announced a two-prong CFS clinical mission for November and December 2009.

The Company plans to widen its ongoing clinical programs in CFS by accelerating collaborations with a consortium of researchers who have just discovered a retroviral link to Chronic Fatigue Syndrome (please see October 8, 2009, online issue of Science). A clinically validated test to detect retrovirus antibodies in patients plasma is also currently under development (please see US National Institutes of Health at:
http://www.cancer.gov/newscenter/pressreleases/CFSxmrv ).

With the consortium of researchers at the Whittemore Peterson Institute, the Company is also now evaluating the defect in immunosurveillance in specific subsets of CFS patients in a clinical study entitled “Therapeutic Activation of NK lymphocytes to Alleviate Chronic Fatigue Syndrome.” These immune defects may be due to the previously undetected retrovirus…

Read full Press Release here

—————-

About.com  Fibromyalgia  and CFS Blog  | November 3, 2009

http://chronicfatigue.about.com/b/2009/11/03/chronic-fatigue-syndrome-dr-lerner-on-ampligen-xmrv.htm

Chronic Fatigue Syndrome: Dr. Lerner on Ampligen, XMRV

By Adrienne Dellwo, About.com Guide to Fibromyalgia & CFS

Dr. A Martin Lerner: Thoughts on XMRV (Updated), Ampligen

In my recent conversation with Dr. A. Martin Lerner, a former chronic fatigue syndrome sufferer who says he used his specialty in infectious diseases to find treatments for himself and others, I asked him about both the XMRV discovery (which was just days old at the time) and also about Ampligen, the proposed chronic fatigue syndrome drug currently awaiting FDA approval…

Read full article here

—————

Commentary

From Hillary Johnson, author of “Osler’s Web”:

Website: http://oslersweb.com/

Blog: http://oslersweb.com/blog.htm

2 October 2009 via Co-Cure

“I’ve posted a new blog, “CDC MYOCARDIAL INFARCTION,” which reveals agency staff anxiety over the likelihood of reprisals against the CDC for Bill Reeves’ two-decades con job.

http://www.oslersweb.com/blog.htm?post=643435

“The material comes from an internal CDC web site where anonymous posters chat about what worries them. Over the weekend, several people have sent me comments captured from this site before it was shut down on October 29th.”*

Stephen Ralph, of MEActionUK, also presents a comprehensive link to this site, at: http://www.meactionuk.org.uk/CDC_Chatter_Blog_-_Updated_021109.htm

Ed: Note: The site has not been shut down but access to this particular thread is no longer set for public access.

—————-

For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, Science paper go here: http://wp.me/p5foE-272

Click here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus: CFSAC meeting Day Two

Posted by meagenda on October 30, 2009

XMRV   Retrovirus   Whittemore Peterson Institute   Science   Mikovits   Chronic Fatigue Syndrome

XMRV Media Round up 18    WordPress Shortlink: http://wp.me/p5foE-2fR

Click here for all previous XMRV Media Round ups: http://meagenda.wordpress.com/category/xmrv/

 

XMRV Retrovirus: CFSAC meeting Day Two

The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS).

Wanda K. Jones, DrPH is the CFSAC Designated Federal Official Deputy Assistant Secretary for Health – Women’s Health. For more information, visit http://www.hhs.gov/advcomcfs

For those who won’t be attending Day Two of the CFSAC meeting, today, Friday 30th October, the meeting is being videocast. Time displayed on the NIH site is Eastern Time, Washington DC Local. UK is currently 4 hours ahead of Washington DC  – so 9:00 a.m. Washington DC is 13:00 hours UK time.

If you’re not able to catch all of today’s meeting or missed parts of yesterday’s, videocasts of the entire proceedings will be available shortly from the NIH wesbite ( http://videocast.nih.gov/PastEvents.asp ). I will post the links once these are online. 

The CFCAS meeting will begin to stream live from the meeting room a few minutes before 1.00 p.m. UK time, with the audio off.  Microphones are turned on just before the meeting is called to order – so don’t think you haven’t got sound. There are simultaneous subtitles.  Today’s meeting is scheduled to adjourn at 4.00 p.m. Washington time (8.00 p.m. UK time). To watch the full day’s proceedings go to this link and scroll down to:

http://videocast.nih.gov/    RealPlayer required

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2

Day 2 Friday 30th October   9:00 a.m. to 4:00 p.m.

 

Agendas for Day One and Day Two are here:   AGENDA

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html  

Yesterday’s meeting included presentations by Dr Dan Peterson, Dr John Coffin (co-author of the Science “Perspective” article) and Dr David Bell, who spoke on MSpB (FII).

Dr Bell’s PowerPoint Slides can be viewed here:

http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt 

 

YouTube

Clips of Dr Dan Peterson and Annette Whittemore:  http://www.youtube.com/user/Khalyal

7 uploads so far

Also here with some patient testimonies:

http://www.youtube.com/user/luminescentfeeling#p/u/2/80yKflt0tcA

—————-

Whittemore Peterson Website Q & A

http://www.wpinstitute.org/xmrv/xmrv_qa.html

—————-

Kelly reports via Co-Cure  29 October 2009

“An investigative journalism site in Atlanta just posted the following article about the CDC and Reeves.”

Atlanta unfiltered

http://www.atlantaunfiltered.com/2009/10/28/advocates-where-was-cdc-for-milestone-in-chronic-fatigue-syndrome-research/

Advocates: Where was CDC for milestone in chronic fatigue syndrome research?

October 28, 2009 -

Looks like the CDC’s chronic fatigue syndrome research group, led by Dr. William C. Reeves, may have some ’splaining to do today in Washington. A possible research breakthrough — the discovery of a correlation between CFS and a retrovirus related to the AIDS virus — has fired up the medical community in recent weeks. “This is going to create an avalanche of subsequent studies,” Dr. William Schaffner, an infectious disease expert at Vanderbilt University, told the New York Times this month. But will the Centers for Disease Control and Prevention play a role in that research? It hasn’t so far.

—————-

Patient community websites, blogs, commentaries

Cort Johnson’s Phoenix Rising website

Resources, Blog and Forums

http://aboutmecfs.org/Rsrcs/XMRVResources.aspx

—————-

Hillary Johnson, author of Osler’s Web

http://www.oslersweb.com/blog.htm?post=641747

Inside the Labyrinth
BILL REEVES: THE DECIDER

October 24, 2009

—————-

Peggy Munson

“First, Do No Pharma”

http://peggymunson.blogspot.com/

Peggy Munson
Saturday, October 17, 2009

—————-

CFS Patient Advocate

http://cfspatientadvocate.blogspot.com/2009/10/xmrv.html

—————-

Dr Marc-Alexander reports via Co-Cure 

Source: NCBI PubMed
Date: 27 oktober 2009
URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
Topic: XMRV
Ref: The list below illustrates that so far, just 16 papers have been published on the XMRV.

XMRV papers published up to october 27, 2009

Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N.
Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients.
Retrovirology. 2009 Oct 16;6(1):92.

Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA.
Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome.
Science. 2009 Oct 8.

Yan Y, Liu Q, Kozak CA.
Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor.
Retrovirology. 2009 Oct 7;6(1):87.

Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR.
XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.
Natl Acad Sci U S A. 2009 Sep 22;106(38):16351-6.

Stang A, Petrasch-Parwez E, Brandt S, Dermietzel R, Meyer HE, Stuhler K, Liffers ST, Uberla K, Grunwald T.
Unintended spread of a biosafety level 2 recombinant retrovirus.
Retrovirology. 2009 Sep 22;6:86.

Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, Nguyen C, Gaughan C, Kim KA, Bannert N, Kirchhoff F, Munch J, Silverman RH.
Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus related virus), a human retrovirus associated with prostate cancer.
J Virol. 2009 Jul;83(14):6995-7003.

Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M,
Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells.
J Virol. 2009 Jul;83(14):7353-6.

Bisbal C, Salehzada T.
RNase L, a crucial mediator of innate immunity and other cell functions [French].
Med Sci (Paris). 2008 Oct;24(10):859-64.

Fischer N,  Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T.
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.
J Clin Virol. 2008 Nov;43(3):277-83.

Dong B, Silverman RH, Kandel ES.
A natural human retrovirus efficiently complements vectors based on murine leukemia virus.
PLoS One. 2008 Sep 4;3(9):e3144.

Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA.
Integration site preference of xenotropic murine leukemia virus- related virus, a new human retrovirus associated with prostate cancer.
J Virol. 2008 Oct;82(20):9964-77.

Summers K, Crespi B.
Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.
Infect Genet Evol. 2008 May;8(3):297-301.

McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA.
Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate.
Neurology. 2008 Jan 22;70(4):278-83.

Silverman RH.
A scientific journey through the 2-5A/RNase L system.
Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):381-8.

Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH.
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.
 Natl Acad Sci U S A. 2007 Jan 30;104(5):1655-60.

Urisman A,  Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL.
Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
PLoS Pathog. 2006 Mar;2(3):e25. Epub 2006 Mar 31.

(c) 2009 NCBI PubMed

—————-

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), Protests, XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus: What’s coming up?

Posted by meagenda on October 28, 2009

 @ 3.07 pm  UK time  Dr. John Coffin about to start

(Published Online October 8, 2009, Science DOI: 10.1126/science.1181349, Science Express Index

Perspectives, Submitted on July 14, 2009, Accepted on August 31, 2009

A New Virus for Old Diseases? John M. Coffin 1* and Jonathan P. Stoye 2)

Update @  2.26 pm  UK time  Dan Peterson XMRV presentation about to start

Perspective on XMRV and Human Retroviruses  Dr. John Coffin Tufts University Boston, Massachusetts scheduled to follow on from Dan Peterson’s presentation.

Update @ 1.oo pm  UK time

CFCAS meeting about to start and is already live streaming from meeting room with simultaneous subtitles click here:

http://videocast.nih.gov/   RealPlayer required

 

Click here for   AGENDA

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html  

——————————————————————–

XMRV   Retrovirus   Whittemore Peterson Institute   Science   Mikovits   Chronic Fatigue Syndrome

XMRV Retrovirus: What’s coming up?

WordPress Shortlink: http://wp.me/p5foE-2fa

Media

News4

http://www.krnv.com/Global/story.asp?S=11402586

Reno scientists prepare to address federal health officials

Victoria Campbell  |  News 4  |  28 October 2008

Just weeks after a medical breakthrough that pinpointed a virus that may be linked to Chronic Fatigue Syndrome, the doctor who helped lead the medical team is preparing to present his findings to an advisory committee from the U.S. Department of Health and Human Services… Read full article here

—————-

CFCAS meeting

For those who won’t be attending the CFSAC meeting, on Thursday 29th and Friday 30th October, the meeting is being videocast at the following links:

UK is currently 4 hours time difference with Washington DC  – so 9:00 a.m. Washington DC is 13:00 hours UK time.

Day 1 Thursday 29th October   9:00 a.m. to 5:00 p.m.

http://videocast.nih.gov/summary.asp?live=7908

Dr Daniel Peterson’s presentation is scheduled for 10:15 a.m.

Dr David Bell’s presentation is scheduled for 3:30 p.m.

Dr Bell’s PowerPoint Slides can be viewed here:

http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt

 

Day 2 Friday 30th October   9:00 a.m. to 4:00 p.m.

http://videocast.nih.gov/summary.asp?live=7909

The number of computers logging on and watching are going to be counted by the NIH. For those who aren’t able to watch live, archived video will be available at:

http://videocast.nih.gov/PastEvents.asp

Click here for   AGENDA

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html  

CFSAC Agenda – October 29-30, 2009

U.S. Department of Health and Human Services

—————-

Video of University of the Pacific Public Presentation on the XMRV/CFS discoveries

On 26 October, Dr Judy Mikovits gave a Public Presentation on the XMRV/CFS discoveries at the University of the Pacific. It’s understood that a videocast of the presentation (which is said to have included new material not yet reported on) will shortly be available.  I will update once the video has been released.

News Release here:

15 October 2008

http://web.pacific.edu/x31783.xml

Fatigue Syndrome Researchers to Speak on Campus

—————-

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CBT/GET, CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

Dr Nigel Speight resigns from children and young person’s organisation AYME

Posted by meagenda on October 27, 2009

Dr Nigel Speight resigns from the children and young person’s organisation AYME

For many years, paediatric specialist, Dr Nigel Speight, has been a champion of families with a child or young person with ME or where ME is suspected. 

He has advocated for families facing wrongful accusation of MSpB (FII), where child protection orders have been instigated or threatened following disagreements between the family and the child’s medical professionals over the management of the condition, where medical professionals have been unwilling to make a diagnosis of ME and where social services have become involved in the case when a child or young person has been unable to regularly attend mainstream school due to ill health.

Dr Speight recently announced his resignation as a Patron to the children and young person’s patient organisation, AYME [Association of Young People with ME]  http://www.ayme.org.uk/.

AYME’s Medical Advisor is Dr Esther Crawley, Consultant Paediatrician at the Royal National Hospital for Rheumatic Diseases NHS Foundation Trust. Dr Crawley had been a member of the NICE CFS/ME Guideline Development Group. 

Dr Speight, who is now retired from the NHS, has become a Medical Advisor to the 25% M.E. Group.

The following announcement was published in a recent 25% M.E. Group newsletter:

I just thought I should inform you officially that after a long and happy association with AYME I have decided to resign as their Patron. Without going into too much detail I would say that over the last couple of years I have become aware that they have changed their position on several areas and that our views have accordingly diverged. In particular AYME seem to have become more willing to collaborate with the medical and psychiatric establishment in order to appear respectable. This appears to have been the cause of AYME’s relative enthusiasm for the NICE Guidelines, which most of us feel involve an overemphasis on CBT and GET. This compromise seems to have helped the psychiatrists to get a new lease of life.

The result of all this is that AYME appear to have alienated themselves from most of the other ME charities (with the exception of AfME [Action for M.E.] who appear to be taking a similar position). In this controversy I feel more in sympathy with the rest of you. I have gained the impression that AYME no longer appreciate my opinions and prefer my status as their figurehead to be a largely silent one. It is a combination of all these factors that has caused me to resign and I am sure you will all understand.

With Best Wishes

Nigel Speight

Posted in 25% ME Group, AYME, AfME, Action for M.E., CBT, CBT/GET, Child protection, ME in children, MSBP (FII), NICE, NICE CFS/ME guideline, NICE Judicial Review, The Young ME Sufferers Trust | Comments Off

Interim XMRV Guidelines National Cancer Institute, testing and CFSAC meeting

Posted by meagenda on October 27, 2009

Interim XMRV Guidelines National Cancer Institute, testing and CFSAC meeting videocasts Media Round up: 17

WordPress Shortlink: http://wp.me/p5foE-2eh

Find all previous Media Round ups, including patient organisation statements, archived under the XMRV Category tab.

Patient representation organisation statements

CFIDS Association of America

http://www.cfids.org/temp/xmrv-guidelines-nci.asp

Interim XMRV Guidelines from National Cancer Institute

(Following the Oct. 8 publication by Lombardi et al in Science linking CFS and xenotropic murine-related retrovirus (XMRV) (see page 1), the CFIDS Association of America requested guidance from the National Cancer Institute about XMRV for persons diagnosed with CFS, their loved ones and the general public. The following are interim guidelines excerpted from a letter received from NCI director Dr. John E. Niederhuber.)

Interim XMRV Guidelines from National Cancer Institute

We at the National Cancer Institute (NCI) have great interest in these initial research findings. At present, we agree that a critical issue to be addressed is whether the exciting recent results obtained using samples from the Nevada cohort can be reproduced in additional cohorts of CFS-afflicted individuals. The NCI is striving to develop tools so that the general prevalence of XMRV in the population can be ascertained, and the association of XMRV with disease can be examined.

In the meantime, it is very important to reiterate what we do not know at this point, specifically:

We do not know whether XMRV is a causative agent for CFS, prostate cancer, or any other disease. Even if a causal association can be established, it may be only one of many causes, and there may be other factors, genetic or environmental, that determine the outcome of infection. At the moment, there is no evidence of CFS transmission between family members, even though XMRV appears to be an infectious agent. Thus, it is unclear whether XMRV alone underlies CFS.

We do not know how XMRV is transmitted from individual to individual. Recent suggestions of sexual or salivary transmission are not based on direct evidence, and conclusions regarding transmission are not credible at this point. Given the frequent isolation of virus from white blood cells, blood-borne transmission is a real possibility, and, while we are not in a position to establish firm guidelines, prudence would dictate that potentially infected individuals refrain from blood donation at this time.

We do not know how many apparently healthy individuals are infected, and what the distribution of infection is within the U.S. and in the worldwide population. The National Cancer Institute is involved in coordinating a global effort to study these issues.

It is very important to keep in mind that there is no evidence for a new increasing or spreading XMRV infection. Further, no credible evidence exists for direct transmission of either CFS or prostate cancer.

John E. Niederhuber, M.D.
Director, National Cancer Institute
U.S. National Institutes of Health
Department of Health and Human Services
October 23, 2009

—————-

Prohealth

http://www.prohealth.com/library/showarticle.cfm?libid=14963

Cooperative Diagnostics Offers Test for XMRV Virus – By Mail, “No Lab Visit or Doctor Approval Necessary”

October 26, 2009

Cooperative Diagnostics, LLC has announced the availability to the general public of a new diagnostic assay for Xenotropic Murine Leukemia-Related Virus (XMRV). For details, go to www.codiagnostics.com/XMRV/index2.php

Those interested in obtaining a blood sample collection kit (price $399) may complete an online form at the Cooperative Diagnostics site. According to the instructions:

• A sample collection kit will be sent to the address you submit within 2 to 3 business days.

• You place a drop of your blood on a filter paper that is provided and return the envelope to the lab, where the test will be completed.

• Within 5 to 7 business days after the lab receives the sample you will be sent an e-mail with the test results.

• The test results may be printed to show your physician.

Positioning the test as intended “to assist physicians in the diagnosis of ME/CFS and other disorders potentially caused by the virus, Cooperative Diagnostics cautions that it “is not intended to indicate the presence of absence of CFS or other X-associated neuro-immune diseases. Consultation with your physician is necessary to interpret the results.”  Read full piece here

—————-

CFSAC meeting

From: “RESCIND”  via Co-Cure
26 October 26 2009

Log on and be counted!

Please distribute far and wide!

For those who won’t be attending the CFSAC meeting, be sure to tune in to the videocast of the CFSAC meeting on October 29th and 30th at the following links:

Day 1

http://videocast.nih.gov/summary.asp?live=7908

Day 2

http://videocast.nih.gov/summary.asp?live=7909

The number of computers logging on and watching will be counted by the NIH. Let’s make those figures count for something!

For those who can’t watch live, archived video will be available at:

http://videocast.nih.gov/PastEvents.asp

—————-

Click for   AGENDA

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html  

CFSAC Agenda – October 29-30, 2009

U.S. Department of Health and Human Services

—————-

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

We call on the Centers for Disease Control and Prevention (CDC) to stop using the “empirical” definition[1] (also known as the Reeves 2005 definition) to define Chronic Fatigue Syndrome (CFS) patients in CFS research.

The CDC claim it is simply a way of operationalizing the Fukuda (1994) definition[2]. However the prevalence rates suggest otherwise: the “empirical” definition gives a prevalence rate of 2.54% of the adult population[3] compared to 0.235% (95% confidence interval, 0.142%-0.327%) and 0.422% (95% confidence interval, 0.29%-0.56%) when the Fukuda definition was used in previous population studies in the US[4,5].

The definition lacks specificity. For example, one research study[6] found that 38% of those with a diagnosis of a Major Depressive Disorder were misclassified as having CFS using the empirical/Reeves definition.

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

Lecture by Nancy Klimas MD: The New XMRV Virus and What it Means to Chronic Fatigue Syndrome Patients

Posted by meagenda on October 25, 2009

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

WordPress Shortlink for Media Round up: 15: http://wp.me/p5foE-2dr

Lectures and presentations

From Marly C. Silverman via Co-Cure
24 October 2009

Lecture by Nancy Klimas, M.D.: The New XMRV Virus and What it Means to Chronic Fatigue Syndrome Patients Media Round up: 15

The New XMRV Virus and What it Means to Chronic Fatigue Syndrome Patients

Join us in a special lecture by Nancy Klimas, M.D. for a discussion on exciting new research advances in chronic fatigue syndrome (CFS). Dr. Klimas is a professor of medicine, psychology, and microbiology and immunology at the University of Miami Miller School of Medicine and the Miami Veterans Affairs (VA) Medical Center.

Dr. Klimas directs the UM/VAMC Gulf War and Chronic Fatigue Syndrome Research Center, initiated with a National Institutes of Health (NIH) Center Award, and supported by VA and NIH funds. The center has focused on better understanding of the neuro-immune-endocrine interactions in CFS and Gulf War Illness (GWI), and their role in the pathogenesis of these complex disorders. She is the immediate past president of the International Association for Chronic Fatigue Syndrome (IACFS-ME), the organization of researchers and clinicians dedicated to furthering our knowledge of this disabling illness. Currently, she is a member of the congressional HHS Advisory Committee , and is a distinguished member of the Medical Advisory Board of P.A.N.D.O.R.A.

Date/Time: Saturday, November 7, 2009, 2-4pm

Location: University of Miami Miller School of Medicine, Rosenstiel Medical Science Building, 1600 NW 10th Avenue, 3rd floor auditorium, Miami, Florida.

Sponsored: By P.A.N.D.O.R.A. – Patient Alliance for Neuroendocrineimmune Disorders Organization for Research and Advocacy Inc, a 501 c 3 patient advocacy organization headquartered in Coral Gables, Florida, in partnership with CFSKnowledgecenter.com  and the local empowerment/support groups in South Florida.

Cost: Free, space is limited

RSVP: The auditorium holds 150 and to ensure refreshments and a “goodies bag” is held for you, RSVP today to Elizabeth Goldberg at egoldberg@med.miami.edu or 305-243-3492.

Parking: Park Plaza West Garage

Direction to Parking Garage:

From I-95, points north
Exit I-95 at SR 836 West, exit number 3-A. Take the NW 14th Street exit. Continue straight on NW 14th Street. Turn right onto NW 12th Avenue. Take a right onto NW 16th Street. Yield at the sign and take a right into the parking lot.

From I-95, points south and east
Exit I-95 at SR 836 West, exit number 3-A (left exit). Exit SR 836 at NW 12th Avenue and turn right onto NW 12th Avenue. Turn right onto NW 16th Street and continue on NW 16th Street. Yield at the sign and take a right into the parking lot.

From SR 836, the Airport, and points west
Take SR 836 East and exit at NW 17th Avenue, North. Pay $1.25 toll and follow the Hospitals and Civic Center Exit. Follow the signs and curve to the left. Turn right towards North, NW 17th Avenue. Stay in the right lane and bear to the right. Yield at the sign and merge into the far left lane. Turn left onto NW 13th Terrace; continue straight onto NW 14th Street. Take left onto NW 12th Avenue. Turn right onto NW 16th Street and continue on NW 16th St. Yield at the sign and take a right into the parking lot.

Directions from Garage to Rosenstiel Medical Science Building: Exit the garage at the north end. Once on the ground floor, follow the sidewalk east on 16th Street (the same street at which you entered the garage). Rosenstiel Medical Science Building is approximately 50 yards on the right. Upon entering Rosenstiel Medical Science Building, inform the security guard that you are attending the CFS seminar. Take the elevator to the third floor and follow the signs to the auditorium.

—————-

CFSAC (CHRONIC FATIGUE SYNDROME ADVISORY COMMITTEE) meeting October 29-30, 2009

10:15 a.m.   Presentation: XMRV Association with CFS   Dr. Daniel Peterson   Whittemore Peterson Institute

3:30 p.m.   CFS and FII/MBP   Dr. David Bell

In a post on 16 October

CFSAC Agenda Presentation: XMRV Association with CFS Dr D Peterson  WordPress Shortlink: http://wp.me/p5foE-2ba

I flagged up the forthcoming CFSAC (CHRONIC FATIGUE SYNDROME ADVISORY COMMITTEE) meeting.

For Supplementary Information see PDF:  http://edocket.access.gpo.gov/2009/pdf/E9-21334.pdf  or html:

http://edocket.access.gpo.gov/2009/E9-21334.htm

Click for   AGENDA

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html  

CFSAC Agenda – October 29-30, 2009

U.S. Department of Health and Human Services

 

Videocasts

Both days of this meeting will be videocast (Realplayer required)

Go to the NIH website at: http://videocast.nih.gov/FutureEvents.asp

Scroll down to October 29th Chronic Fatigue Syndrome link for: http://videocast.nih.gov/summary.asp?live=7908

Air date: Thursday, October 29, 2009, 9:00:00 AM
Time displayed is Eastern Time, Washington DC Local

October 30th Day 2: http://videocast.nih.gov/summary.asp?live=7909

You will be able to view the event at: http://videocast.nih.gov  when the event is live.

FAQ on video streaming at: http://videocast.nih.gov/faq/

The videocast will be archived for a few weeks after the meeting.  Mintutes of the meeting will be posted on the CFSAC website with archived copies of the testimonies provided for the meeting.

CFSAC webpage:  http://www.hhs.gov/advcomcfs/

 

Videocasts of Days One and Two of the previous meeting (27 – 28 May 09) can still be viewed at:

http://www.hhs.gov/advcomcfs/ 

Day One: Wed 27 May: http://videocast.nih.gov/Summary.asp?File=15130  (Realplayer required)

Day Two: Thurs 28 May: http://videocast.nih.gov/Summary.asp?File=15136  (Realplayer required)

—————-

Commentary

From: RESCIND via

Help ME Circle 25 October 2009
Editorship : j.van.roijen@chello.nl  

***Please distribute far and wide!***

RESCIND rescindinc.org@gmail.com

Support the 500 Professionals of the IACFS/ME – Reeves Must Go

On May 27th and May 28th, 2009, the Chronic Fatigue Syndrome Advisory Committee (CFSAC) convened in Washington, D.C. Among their recommendations to the Secretary of Health and Human Services was a call for new and progressive leadership at the CDC’s ME/CFS research division.

We, the public, need to back the IACFS/ME and the CFSAC. Under Bill Reeves’ regime, funding has routinely decreased and increasingly broad definitions which have ceased to have any clinical meaning or research value have been implemented.

Under Reeves’ direction the CFS program is being slowly strangled.

A couple of weeks ago, Dr. Judy Mikovits, who is a retrovirus expert at the Whittemore Peterson Institute, released the results of a study which provided overwhelming evidence that xenotropic murine leukemia virus-related virus, or XMRV, could very well be the third human retrovirus.

Mikovits found that in a study of 101 CFS patients, 67% were found to have XMRV in their cells, but this is really not new news. In 1991 Dr. Elaine Defreitas found retroviral DNA in 80% of her study’s 30 CFS patients. The CDC “replicated” her study, did not follow her exact procedure, and ended the study prematurely while ostracizing Defreitas.

What does Reeves say about Mikovits recent discovery? Without doing any study or due diligence Reeves dismisses  the findings by saying that they are “unexpected and surprising” and that it is “almost unheard of to find an association of this magnitude between an infectious agent and a well-defined chronic disease, much less an illness like CFS.”

Deceit and incompetence have increasingly become the order of the day. The money that Bill Reeves has been receiving has been terribly mismanaged as he desperately strives to forestall the slow but inevitable pace of biomedical research.

Inappropriate management of funds prevents collaboration with biomedical experts, as well as collaboration with psychosocial experts who are not trying to build a career in psychosomatic medicine.

Bill Reeves must be held accountable.

Inaccurate stereotypes persist because Bill Reeves has not been accurately educating the public on the seriousness of this disease.

CFS is not a disease of “feeling a little tired,” no matter what you call it; this is a severe neuro-immune disease of among other things, debilitating exhaustion completely out of proportion to exertion. Patients may be too exhausted to even be able to chew their food, leave their beds and much less even work – and remain so year after year. Is that your neighbor’s experience of tired?

Perhaps you suffer from CFS, perhaps your patients do, or perhaps a loved one does; your best interests are not and have not been at the heart of the CDC’s program. What’s at the heart of the program is job security for Bill Reeves, his paycheck and collaboration with his pals – not finding ways to combat and track this horrible disease.

We need you now more than ever. Right now is the first real chance that we have had in nearly 30 years to fight Reeves in force; to fight for you, your loved ones, or your patients. Everyone from researchers to advocates are in agreement – Reeves must go. And we must make it happen. No one will do it for us.

Join members of the IACFS/ME at the CFSAC’s October 29-30th meeting in Washington, D.C. Do not let the hard work of other advocates and researchers over the years be for nothing. We need to show that we cannot be silenced and we will never give up.

If you cannot personally attend, find someone to attend in your place. Ask your parents, your children, your spouses or friends to attend in your place. Ask your elected officials to have aids attend.

The answer is always no if you don’t ask – we must make it happen – none of us can live with the alternative.

Reeves must go.

—————-

Reeves CF Definition Petitition

From Tom Kindlon

“Please use whatever resources you have access to (e.g. blogs, Twitter, Facebook, other social networking sites, newsletters, E-mail lists/discussion forums, etc) to highlight the existence of the petition. The petition also links to some critiques of the definition. Many people have also written interesting comments.

Note: I have no intention of closing the petition site until the CDC stop using this flawed definition.”

I’m appending the text of the petition below with a link.

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

The petition

We call on the Centers for Disease Control and Prevention (CDC) to stop using the “empirical” definition[1] (also known as the Reeves 2005 definition) to define Chronic Fatigue Syndrome (CFS) patients in CFS research.

The CDC claim it is simply a way of operationalizing the Fukuda (1994) definition[2]. However the prevalence rates suggest otherwise: the “empirical” definition gives a prevalence rate of 2.54% of the adult population[3] compared to 0.235% (95% confidence interval, 0.142%-0.327%) and 0.422% (95% confidence interval, 0.29%-0.56%) when the Fukuda definition was used in previous population studies in the US[4,5].

The definition lacks specificity. For example, one research study[6] found that 38% of those with a diagnosis of a Major Depressive Disorder were misclassified as having CFS using the empirical/Reeves definition.

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

—————-

Scientific papers

The 1991 DeFreitas paper

Abstract and Full text here: http://www.pnas.org/content/88/7/2922.full.pdf+html

Proc. Natl. Acad. Sci. USA
Vol. 88, pp. 2922-2926, April 1991
Medical Sciences

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome

(Epstein-Barr virus syndrome/infectious mononucleosis/myalgic encephalomyelitis/polymerase chain reaction/in situ hybridization)

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104

Contributed by Hilary Koprowski, November 13, 1990

ABSTRACT Chronic fatigue immune dysfunction

Chronic fatigue immune dysfunction syndrome (CFIDS) is a recently recognized illness characterized by debilitating fatigue as well as immunological and neurological abnormalities [Straus, S.E. (1988) J. Inf. Dis. 157, 405-412]. Once thought to be caused by Epstein-Barr virus, it is now thought to have a different but unknown etiology. We evaluated 30 adult and pediatric CFIDS patients from six eastern states for the presence of human T-lymphotropic virus (HTLV) types I and II by Western immunoblotting, polymearse chain reaction, and in situ hybridization of blood samples. The majority of patients were positive for HTLV antibodies by Western blotting and for HTLV-II gag sequences by polymerase chain reaction and in situ hybridization. Twenty nonexposure healthy controls were negative in all assays. These data support an association between an HTLV-II-like virus and CFIDS.

—————-

Previous ME agenda Media Round-ups listed at the foot of this post: http://wp.me/p5foE-2cS

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

IACFS/ME statement, CFSAC meeting, Reeves CFS Definition Petition

Posted by meagenda on October 23, 2009

Whittemore Peterson XMRV link with CFS study Media Round up: 14

WordPress Shortlink: http://wp.me/p5foE-2cS

IACFS/ME statement: New Study finds link between XMRV retrovirus and CFS/ME

IACFS/ME’s Recommendations:
CDC’s Five Year Strategic Plan for CFS Research

Date: October 21, 2009

New Study finds link between XMRV retrovirus and CFS/ME

An article published online (10/8/09) in the journal Science reported that 68 of 101 patients with CFS, or 67 percent, were infected with an infectious virus, xenotropic murine leukemia virus-related virus, or XMRV. By contrast, only 3.7 percent of 218 healthy people were infected. XMRV is a retrovirus, a member of the same family of viruses as the AIDS virus. These viruses carry their genetic information in RNA rather than DNA, insert themselves into their hosts’ genetic material, and stay for life.

These new findings raise the possibility that XMRV could be a possible cause of the illness or an effect of altered immune function in CFS patients who are more susceptible to these viruses. More studies are needed to explain the occurrence of XMRV in the genetic material of CFS patients.

The research was carried out by principal investigator Judy Mikovits and colleagues from the Whittemore Peterson Institute, the National Cancer Institute, and the Cleveland Clinic in the US.

This new finding about the XMRV virus is an exciting development, although its significance has yet to be determined. First, the study needs to be replicated in well-defined CFS samples in the community and in physician’s offices. Prospective studies (following patients over time) are essential to determine if the virus is contributing to the cause, persistence, and/or severity of the illness.

The good news is that if XMRV is linked to CFS, there are many antiviral drugs that have already been safety tested in H.I.V. that may inhibit XMRV replication. Thus studies to determine the safety and efficacy of these antiviral agents for CFS/ME patients could be designed and executed in short order.

Important Meeting of the CFS Advisory Committee

on Oct. 29-30 in Washington, DC

http://www.hhs.gov/advcomcfs/meetings/agendas/cfsac091029_agenda.html

The CFS Advisory Committee makes recommendations to the Secretary of Health and Human Services regarding government-based CFS research, funding and programs. This is a critical meeting because the future of $25 million in public funding for CFS research at the Centers for Disease Control will be discussed. IACFS/ME wants these funds to be spent on cutting edge biomedical research leading to objective diagnosis and treatment of CFS. We also want CFS to become a public health priority so that issues of stigma and the absence of good medical care are addressed.

The new CFS retroviral study on XMRV in the top tier journal Science shows what can be done to advance the medical research. But this is only a first step. Without follow-up, the momentum we now have will be lost. Only with broad based support from the professional and patient communities will we have a voice in how federal funds for CFS research are spent.

What we need is strong attendance at the CFSAC meeting. If we pack the house (we have to fill only 50 seats), that will show that we care about this illness and support all appropriate biomedical research and public policy initiatives that legitimize CFS. If you can attend for even 2 hours that would be helpful.

For an informative Q and A about the study, click on the link below:

http://www.wpinstitute.org/xmrv/xmrv_qa.html

Fred Friedberg, PhD
President
IACFS/ME

———————

Tom Kindlon  21 October 2008, via Co-Cure

Reeves Criteria Petition update: Marly Silverman (Pandora) to bring petition print-out to CFSAC meeting

Marly “Marla” C. Silverman, Founder of P.A.N.D.O.R.A. (Patient Alliance for Neuroendocrineimmune Disorders Organization for Research & Advocacy, Inc http://www.pandoranet.info) has been in touch to say that she will be bringing a print-out of the “entire petition” (i.e. the visible signatures and comments) to the CFSAC meeting at the end of October.

Please use whatever resources you have access to (e.g. blogs, Twitter, Facebook, other social networking sites, newsletters, E-mail lists/discussion forums, etc) to highlight the existence of the petition. The petition also links to some critiques of the definition. Many people have also written interesting comments.

Note: I have no intention of closing the petition site until the CDC stop using this flawed definition.

I’m appending the text of the petition below with a link.

Tom Kindlon

http://CFSdefinitionpetition.notlong.com
i.e.
http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

The petition

We call on the Centers for Disease Control and Prevention (CDC) to stop using the “empirical” definition[1] (also known as the Reeves 2005 definition) to define Chronic Fatigue Syndrome (CFS) patients in CFS research.

The CDC claim it is simply a way of operationalizing the Fukuda (1994) definition[2]. However the prevalence rates suggest otherwise: the “empirical” definition gives a prevalence rate of 2.54% of the adult population[3] compared to 0.235% (95% confidence interval, 0.142%-0.327%) and 0.422% (95% confidence interval, 0.29%-0.56%) when the Fukuda definition was used in previous population studies in the US[4,5].

The definition lacks specificity. For example, one research study[6] found that 38% of those with a diagnosis of a Major Depressive Disorder were misclassified as having CFS using the empirical/Reeves definition.

References

[1] Reeves WC, Wagner D, Nisenbaum R, Jones JF, Gurbaxani B, Solomon L, Papanicolaou DA, Unger ER, Vernon SD, Heim C. Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med. 2005 Dec 15;3:19. Link: http://www.biomedcentral.com/1741-7015/3/19

[2] Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome; a comprehensive approach to its definition and study. Ann Int Med 1994, 121:953-959.

[3] Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva RS, Morrissey M, Devlin R. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr. 2007 Jun 8;5:5.

[4] Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, Stewart JA, Abbey S, Jones JF, Gantz N, Minden S, Reeves WC: Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Int Med 2003, 163:1530-1536.

[5] Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S. A community-based study of chronic fatigue syndrome. Arch Intern Med. 1999 Oct 11;159(18):2129-37.

[6] Jason, LA, Najar N, Porter N, Reh C. Evaluating the Centers for Disease Control’s empirical chronic fatigue syndrome case definition. Journal of Disability Policy Studies 2008, doi:10.1177/1044207308325995.

Further reading:
Problems with the New CDC CFS Prevalence Estimates Leonard Jason, Ph.D., DePaul University
http://tinyurl.com/2qdgu4  i.e.
http://www.iacfsme.org/IssueswithCDCEmpiricalCaseDefinitionandPrev/tabid/105/Default.aspx

———————

Prohealth

[Ed: Note: Dr David Bell will be presenting at the Thursday Session of the CFSAC (CHRONIC FATIGUE SYNDROME ADVISORY COMMITTEE) 29-20 October meeting at 3:30 p.m. and speaking on CFS and FII/MBP.  See http://wp.me/p5foE-2dr under Lectures and presentations.]

http://www.prohealth.com/library/showarticle.cfm?libid=14942

Dr. David Bell on XMRV Research: “Now We Can Get Down to Business”
by David S Bell, MD, FAAP
October 21, 2009

This information is reproduced with kind permission from the October 2009 issue of Dr. Bell’s free Lyndonville News e-newsletter. It was published shortly after research linking the “XMRV” retrovirus and ME/CFS went live in the journal Science on October 8.
______________________

Holy smokes! Just when I want to retire this comes along. How am I going to get any peace and quiet?

Here is the Lyndonville News coming out within a week of a paper being published, and already what I have to say is old news. Probably everyone reading this newsletter has been on the edge of their seats listening to NPR, CBS, Reuters, and so on. The CDC has already said that it isn’t going to pan out. It is my guess that the media coverage will intensify because this is really big news.

First of all, congratulations…

To Drs. Judy Mikovits, Vincent Lombardi, Robert Silverman, Dan Peterson and the rest of the authors. And a special congratulations to the Whittemore Family Foundation, and the Whittemore-Peterson Institute for putting this together. For many years ME/CFS has been limping along on complex science that points to mechanisms of illness that most physicians have ignored. Limped along with skeptical specialists, medical establishments, government agencies. Limped along despite attacks by disability companies. Now we can get down to business…

Full article here

 

Previous ME agenda Media Round ups

Round up 14: Whittemore Peterson XMRV link with CFS study Media update: 14: http://wp.me/p5foE-2cS  (you are here)

Revised MEA statement on retrovirus XMRV and ME/CFS (Version 2): http://wp.me/p5foE-2cD

Round up 13: NIH $1.6 Million award for ME/CFS Research for Drs. Mikovits & Kerr: http://wp.me/p5foE-2co 

Round up 12: XMRV Retrovirus Whittemore Peterson CFS study Media Round up 12: http://wp.me/p5foE-2c2

Round up 11: XMRV Retrovirus Whittemore Peterson CFS study Media Round up 11: http://wp.me/p5foE-2bB

Round up 10: Whittemore Peterson Institute XMRV retrovirus study link with CFS (Science journal):
http://wp.me/p5foE-2bk

Round up 9: Notice from Dr David Bell, Lyndonville News; Article by Paul R. Cheney MD, PhD:
http://wp.me/p5foE-2aQ

Round up 8: XMRV retrovirus study: Position statement from ME Association 14.10.09: http://wp.me/p5foE-2at

Round up 7: XMRV Retrovirus: Whittemore Peterson Institute: CFS: Media Round up 7: http://wp.me/p5foE-2aa

Round up 6: XMRV Retrovirus: Whittemore Peterson Institute Chronic Fatigue Syndrome study: Videos and audios: http://wp.me/p5foE-29L

Round up 5: Supporting Online Material for XMRV Chronic Fatigue Syndrome study: http://wp.me/p5foE-299

Round up 4: XMRV Retrovirus: Whittemore Peterson Institute Chronic Fatigue Syndrome study:
http://wp.me/p5foE-28F

Round up 3: Whittemore Peterson Institute (WPI) Chronic Fatigue Syndrome retrovirus XMRV in the media: http://wp.me/p5foE-280

Round up 2: Science 9 October 2009: Whittemore Peterson Institute (WPI) Chronic Fatigue Syndrome link to retrovirus: 08.10.09: http://wp.me/p5foE-27v

Round up 1: Whittemore Peterson Institute (WPI) Chronic Fatigue Syndrome link to retrovirus: 09.10.09: http://wp.me/p5foE-272

Posted in CFS Research, CFS in the media, CFSAC, ME Research, ME events, ME in journals, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off